In:
Journal of Politics and Law, Canadian Center of Science and Education, Vol. 9, No. 9 ( 2016-10-30), p. 195-
Abstract:
〈 span lang="EN-US" 〉 It is necessary to play a leading and exemplary role in the implementation of Chinese innovative development strategy, because of the economic, social and political status of state-owned pharmaceutical enterprises. Based on describing pharmaceutical ownership reforming and innovation status, the paper analyzed the dynamic innovation performance of the State-owned pharmaceutical enterprises by the Malmquist index of DEA (Data Envelopment Analysis), and result shows that the biological product field of state-owned enterprises obtained better innovation performance. Then the paper discussed the innovation performance of state-owned pharmaceutical enterprises by the empirical analysis of Panel data model, the results showed that the state-owned enterprise have the serious status of R & amp;D resource concentrating and excessing, but it is still achieve major force of Chinese pharmaceutical economic growth based on innovative activities. At last, the paper offered the upgrading road of state-owned enterprises innovation capability, such as the market radiating and integrating, micro-cooperation, organizational restructuring, and cross-regional integration. 〈 /span 〉
Type of Medium:
Online Resource
ISSN:
1913-9055
,
1913-9047
DOI:
10.5539/jpl.v9n9p195
Language:
Unknown
Publisher:
Canadian Center of Science and Education
Publication Date:
2016
detail.hit.zdb_id:
2491398-4
SSG:
2
Permalink
